Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ophthotech Corporation
Age
50–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Active subfoveal NVAMD
You may not be if
History or evidence of severe cardiac disease
Any major surgical procedure within one month of trial entry
Subjects with a clinically significant laboratory value
Any treatment with an investigational agent in the past 60 days for any condition
Women who are pregnant or nursing
Known serious allergies to the fluorescein dye used in angiography, povidone iodine, to the components of the ranibizumab formulation, or to the components of the Zimura formulation
Any prior treatment for AMD other than oral supplements of vitamins and minerals
Clareo Health | ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD)
